Powered by Smartsupp

Light and cholesterol: what does blood lipid research show?

KINGRAY Academy logo
KINGRAY ACADEMY
LASER SERIES · 04

Can a laser lower cholesterol or “clear the arteries”? Small photobiomodulation studies describe changes in certain blood measurements, but a laboratory result is not the same as removing an atherosclerotic plaque or preventing a heart attack. Let us examine what was measured and where the evidence stops. [2][4][5][6][7][8]

Select a question to scroll to its answer within this article.

Author: Ing. František Kokoš
Updated:

What do LDL, HDL and triglycerides mean?

We need cholesterol for cell membranes and the production of certain hormones and bile acids. Lipoprotein particles transport it through the blood. LDL-C measures the cholesterol carried in LDL, and HDL-C the cholesterol carried in HDL. Triglycerides mainly transport and store energy. [1]

Total cholesterol alone does not describe the whole risk. Non-HDL cholesterol, calculated as total cholesterol minus HDL-C, includes cholesterol in atherogenic particles. ApoB helps estimate their number. Results are interpreted alongside age, blood pressure, smoking, diabetes, family history and previous vascular disease. [1][2]

LDL and other apoB-containing particles can be retained in artery walls and contribute to atherosclerosis. The LDL target therefore depends on overall risk; there is no single correct target for everyone. [2]

How do blood lipids relate to microcirculation?

Flow through small vessels also depends on plasma properties, red-cell flexibility and aggregation. Lipid disorders can be associated with these properties, but cholesterol alone does not determine blood flow in every organ. [3]

Nara and colleagues compared 23 people with high cholesterol and 69 with normal levels. Blood from the first group travelled more slowly through laboratory microchannels; transit time was also associated with cholesterol in remnant-like lipoprotein particles. This was an observed association and a laboratory measurement, not direct evidence that light improves blood vessels. [3]

How might light affect fat metabolism?

PBM research investigates light-sensitive cellular structures, mitochondrial energy processes and redox signalling. These processes might indirectly influence fat metabolism. However, a change in a blood test does not reveal which mechanism caused it; the pathway from a particular application to lower cholesterol remains under investigation. [14]

Illuminating the nose or wrist does not directly irradiate the liver. A proposed distant metabolic response is different from illuminating an organ itself. The clinical studies discussed do not establish that a nasal laser specifically activates a liver enzyme or an LDL receptor. [4][9][14]

What did intranasal 650 nm application show?

In 2012, Liu and colleagues studied 90 patients with coronary disease or cerebral infarction. Sixty received active intranasal application and 30 received an inactive control procedure. The authors describe the study as randomised, double-blind and placebo-controlled. [4]

The regimen consisted of two ten-day courses separated by a three-day break, with one 30-minute application daily. This describes a research protocol, not instructions for another device or an individual user. [4]

Total cholesterol and LDL-C

Mean total cholesterol fell from 4.44 to 3.78 mmol/L in the active group and changed from 4.10 to 4.07 mmol/L in the control group. LDL-C changed from 2.73 to 2.48 mmol/L in the active group and from 1.39 to 2.33 mmol/L in the control group. Baseline differences, particularly in LDL, are an important limitation of the comparison. [4]

HDL-C and triglycerides

HDL-C increased from 1.07 to 1.20 mmol/L in the active group and from 1.00 to 1.17 mmol/L in the control group. Triglycerides changed from 1.88 to 1.70 and from 1.85 to 1.87 mmol/L, respectively. The triglyceride decrease in the active group was not statistically significant. These figures are group averages, not a predicted individual response. [4]

The authors also reported changes in some rheological measures. However, before-and-after tests within one group are not the same as a reliable estimate of the treatment difference versus control. The study did not demonstrate fewer heart attacks or strokes and did not measure plaque removal. [4]

What do pilot studies and animal experiments add?

In 2021, Lizarelli and colleagues divided 36 women into six groups. They compared a control group with different 660 nm regimens through the skin, under the tongue and inside the nose. Blood measurements were taken at baseline and after 30 and 60 days. Each group contained only six participants, and changes were not consistent across all measures and time points. [5]

The work can help design further research, but does not identify the best delivery route or establish equivalence between methods. Small groups are sensitive to chance and differences between participants. [5]

In 2016, Wang and colleagues investigated 650 nm light in rabbits with high cholesterol, with five animals per group. They assessed lipids, blood-cell properties, microcirculation and the aorta. Even favourable experimental findings support mechanism research rather than proving the removal of atherosclerosis in humans. [6]

Wrist application: a 2024 metabolic syndrome study

Abd El-sabour and colleagues divided 40 participants into two groups. One received 650 nm wrist laser applications alongside glucose-lowering medicines for 12 weeks; the other received those medicines alone. Participants were not taking statins, and the control group received no sham light application. [9]

The authors reported more favourable lipid changes with added laser treatment. Average LDL-C fell by 17.2%, compared with 8.3% in controls; triglycerides fell by 20.4%, versus 9.6%. These are changes within each group, not the net percentage effect of light alone. [9]

The findings support further controlled testing. However, the small sample, absence of a sham procedure and short follow-up cannot establish long-term heart attack prevention, equivalence to a statin or effectiveness of every laser watch. [9]

Light colour and device type: is there a best option?

The human studies in this article mainly used 650 or 660 nm. They did not adequately compare red, blue and near-infrared light to identify the most effective colour for cholesterol. Dose, illuminated area and tissue also matter; a wavelength in nanometres alone is insufficient. [4][5][9][10]

Intravenous ILIB, nasal application and wrist irradiation are different methods. A polarised biolamp may have a broader spectrum and deliver a different dose from a laser. Results for one method therefore do not establish the effectiveness of another or of a particular home device. [4][5][9][10]

Why is higher HDL not automatically a success?

HDL provides useful information, but raising it does not by itself guarantee lower vascular risk. In AIM-HIGH, adding niacin increased HDL and lowered triglycerides without providing extra clinical benefit over intensive statin treatment alone. [8]

FOURIER also illustrates the distinction between laboratory and health outcomes. In 27,564 patients, adding evolocumab to statin treatment reduced LDL and the occurrence of the cardiovascular events studied. This type of clinical evidence cannot be replaced by measuring lipids after light application alone. [7]

Oxidised LDL: what can the results tell us?

LDL-C measures the cholesterol carried in LDL particles, not their degree of oxidation. Cellular PBM studies also examine oxidative signalling, but a routine lipid panel cannot establish antioxidant protection of LDL. Atherosclerosis involves particle retention in the vessel wall and inflammation; a single marker does not explain it. [2][14]

What is useful to monitor in practice?

Repeat tests should compare the whole lipid profile and record changes in diet, weight, activity, alcohol and medication. Sampling conditions should follow the laboratory’s instructions. Depending on the situation, a clinician may add apoB or lipoprotein(a), which helps assess inherited risk. [1][2]

The foundations are not smoking, appropriate activity and a fibre-containing diet that replaces some saturated fats with unsaturated fats. Medication needs depend on risk and measured levels. Photobiomodulation remains investigational for lipid management, and these studies do not justify stopping prescribed treatment. [2][4][5]

What about familial hypercholesterolaemia?

In this inherited disorder, LDL is often elevated from early life. The light studies discussed do not establish heart attack prevention in this particular group or correction of its genetic cause. Early specialist assessment and family screening are important; effective treatment should not wait for the outcome of trying light. [2][11]

Statins and home light devices: how should a combination be considered?

Statins and other lipid-lowering medicines have their own clinical evidence, and treatment selection depends on overall risk. If a statin causes difficulties, a clinician may adjust the dose or choose another established treatment. Small light studies do not justify stopping medication independently. [2][7]

Nor can the safety of every home-device combination with all medicines be guaranteed. The instructions, application site and medications, including those that increase light sensitivity, need to be considered. The 2024 wrist study did not assess combination treatment with statins because its participants were not taking them. [9][10][12]

When should blood results be checked?

Research sampling schedules do not predict when an effect will appear. The pilot study assessed 30 and 60 days, and the wrist study assessed 12 weeks. Plan follow-up testing with a clinician according to risk and treatment; comparable conditions and a record of other changes help interpret the result. [1][5][9]

Safety and the idea of ‘released fats’

A low-power laser is not automatically risk-free. Protect the eyes as instructed, never direct light into them, and stop application if there is pain, marked heat or irritation. Safety depends on power, dose and use; a short study cannot rule out rare or long-term adverse effects. [10][12]

Blood irradiation should not be confused with body-contouring procedures. A review of 15 papers on localised fat reduction found no consistent significant effect of PBM alone on blood lipids. The idea that a nasal laser dissolves deposits and moves them elsewhere is neither an established mechanism nor a documented typical adverse effect. [13]

Further research needs larger studies with inactive controls, stable accompanying treatment and longer follow-up. Beyond lipid measurements, we need to know whether actual vascular risk changes and whether any benefit persists after applications stop. [4][5][9]

Frequently asked questions

How could light affect cholesterol levels?

Researchers are investigating changes in cellular energy processes and signalling that might affect metabolism. The precise pathway from light application to a change in human blood lipids remains unclear. [14]

What exactly have clinical studies of blood irradiation and lipids found?

Small studies have reported favourable changes in some lipids after nasal or skin application. Findings vary by marker and method; they do not establish heart attack prevention. [4][5][9]

Does light act directly on the liver or through other tissues?

A nasal applicator or wrist device does not illuminate the liver directly. A possible distant metabolic effect is a research question, not proven direct stimulation of liver enzymes. [4][9][14]

Which wavelength is most effective for blood lipids?

These studies cannot identify a winning colour. The human studies mainly examined red light at 650 or 660 nm, rather than reliably comparing all colours. [4][5][9][10]

Can photobiomodulation lower LDL cholesterol and triglycerides?

Some studies have reported this. However, results are inconsistent: the triglyceride reduction in the 2012 nasal study, for example, was not statistically significant. [4][9]

Does light therapy raise HDL cholesterol?

Some studies reported higher HDL-C. Raising this number alone does not demonstrate a reduction in cardiovascular risk. [4][8][9]

Can light protect LDL from oxidation?

Effects on oxidative balance are being investigated. Lower LDL-C on a lipid panel does not by itself establish lower oxidised LDL or protection from atherosclerosis. [4][9][14]

Can blood irradiation reverse atherosclerosis?

The human studies discussed did not demonstrate plaque regression. Favourable animal findings support further research, rather than proving that light clears human arteries. [4][6][9]

How are cholesterol, blood viscosity and microcirculation related?

Lipid disorders may be associated with blood properties, but viscosity also depends on plasma and blood cells. Cholesterol, viscosity and clotting require different assessments. [3]

Does light reduce heart attack risk in familial hypercholesterolaemia?

These studies have not established that clinical benefit in this inherited condition. Early diagnosis, family screening and effective LDL management matter. [2][11]

Can photobiomodulation replace statins?

Not on the basis of this evidence. If a statin is not tolerated, a clinician can adjust treatment or choose another established option. [2][7]

Is combining cholesterol medication with a home laser safe?

The safety of every combination has not been established. Decisions depend on the device, medicines and medical history; do not change prescribed treatment yourself. [9][10][12]

Have nasal applicators, laser watches and biolamps been studied?

Nasal application and skin irradiation at the wrist have their own small studies. Their findings cannot automatically be transferred to a polarised biolamp or another device. [4][5][9][10]

When might blood tests show a change?

Studies assessed different periods, such as 30 and 60 days or 12 weeks. These are neither a guarantee of benefit nor a universal testing schedule; a clinician should plan follow-up. [1][5][9]

What are the risks, and could fats accumulate elsewhere after treatment?

Risks depend on the source, dose and application, including eye injury or tissue irritation. Moving ‘dissolved fats’ from vessels into other organs is not an established mechanism of this method. [10][12][13]

Can cholesterol be determined from a blood drop under a microscope?

A lipid profile requires laboratory testing. The appearance of cells does not provide LDL-C, HDL-C or triglyceride values. [1]

Sources and research

Based on material by Ing. František Kokoš. Updated 10 November 2026. Clinical, pilot and animal findings are distinguished according to the specific method and what was actually measured.

  1. NHLBI, NIH. Blood Cholesterol: Diagnosis.
    Open source ↗
  2. ESC/EAS. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2025;46:4359–4378. DOI: 10.1093/eurheartj/ehaf190.
    Open source ↗
  3. Nara M et al. Impaired Blood Rheology and Elevated Remnant-like Lipoprotein Particle Cholesterol in Hypercholesterolaemic Subjects. J Int Med Res. 2009;37:308–317. DOI: 10.1177/147323000903700204.
    Open source ↗
  4. Liu TCY et al. Randomized, Double-Blind, and Placebo-Controlled Clinic Report of Intranasal Low-Intensity Laser Therapy on Vascular Diseases. Int J Photoenergy. 2012:489713. DOI: 10.1155/2012/489713.
    Open source ↗
  5. Lizarelli RFZ et al. A pilot study on the effects of transcutaneous and transmucosal laser irradiation on blood pressure, glucose and cholesterol in women. Heliyon. 2021;7:e07110. DOI: 10.1016/j.heliyon.2021.e07110.
    Open source ↗
  6. Wang H et al. The hematologic effects of low intensity 650 nm laser irradiation on hypercholesterolemia rabbits. Am J Transl Res. 2016;8:2293–2300.
    Open source ↗
  7. Sabatine MS et al. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med. 2017;376:1713–1722. DOI: 10.1056/NEJMoa1615664.
    Open source ↗
  8. AIM-HIGH Investigators. Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy. N Engl J Med. 2011;365:2255–2267. DOI: 10.1056/NEJMoa1107579.
    Open source ↗
  9. Abd El-sabour TS et al. Non-invasive laser therapy effect on lipid profile and renal function in metabolic syndrome: randomized control trial. Bulletin of Rehabilitation Medicine. 2024;23(3):32–39. DOI: 10.38025/2078-1962-2024-23-3-32-39.
    Open source ↗
  10. Zein R, Selting W, Hamblin MR. Review of light parameters and photobiomodulation efficacy: dive into complexity. Journal of Biomedical Optics. 2018;23:120901. DOI: 10.1117/1.JBO.23.12.120901.
    Open source ↗
  11. American Heart Association. What is Familial Hypercholesterolemia? Reviewed 13 March 2026.
    Open source ↗
  12. U.S. Food and Drug Administration. Frequently Asked Questions About Lasers.
    Open source ↗
  13. Sena MM et al. Can the use of photobiomodulation for localized fat reduction induce changes in lipid profile? A critical integrative review. Lasers in Medical Science. 38:23. Online 24 December 2022. DOI: 10.1007/s10103-022-03662-5.
    Open source ↗
  14. de Freitas LF, Hamblin MR. Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy. IEEE Journal of Selected Topics in Quantum Electronics. 2016;22(3):7000417. DOI: 10.1109/JSTQE.2016.2561201.
    Open source ↗
Ing. František Kokoš
Author: Ing. František Kokoš
Ing. František Kokoš – Author of KINGRAY Academy and Advice Corner
Technician, nutrition adviser (graduate of the 150-hour Welko retraining programme, 2025) and creator of the KINGRAY nutraceuticals concept. Years of developing the BIOquant medical device and working with blood rheology and tissue oxygenation led him to realise that bodily health requires the full picture – linking microcirculation, cellular energy and proper nutrition. In his articles, he looks for the balance where the body understands and cooperates with us.
He is the author of the book Liečba svetlom (Light Therapy, ISBN 978-80-970512-0-4), co-author of the publication BIOquant – polovodičová laserová terapia (BIOquant – Semiconductor Laser Therapy, ISBN 978-80-970512-2-8), and originator of patents in light technologies (US9731145B2, SK5457Y1).
%s ...
%s
%image %title %code %s
%s